Navidea CEO to shareholders: Come up with a better idea for raising stock price
July 07, 2017 at 10:47 AM EDT
Michael Goldberg has been a frustrated investor in Navidea Biopharmaceuticals Inc. for 10 years. So he understands, to a point, the anger of shareholders who bought in back in the 1990s, when it was called Neoprobe Corp.
